132 related articles for article (PubMed ID: 23239688)
1. Incidental focal hepatic mass.
Kim YC; Kim JK; Lee JH
Br J Radiol; 2013 Jan; 86(1021):20110659. PubMed ID: 23239688
[No Abstract] [Full Text] [Related]
2. Magnetic resonance imaging of focal liver lesions: approach to imaging diagnosis.
Fowler KJ; Brown JJ; Narra VR
Hepatology; 2011 Dec; 54(6):2227-37. PubMed ID: 21932400
[TBL] [Abstract][Full Text] [Related]
3. Characterization of cirrhotic nodules with gadoxetic acid-enhanced magnetic resonance imaging: the efficacy of hepatocyte-phase imaging.
Chou CT; Chen YL; Su WW; Wu HK; Chen RC
J Magn Reson Imaging; 2010 Oct; 32(4):895-902. PubMed ID: 20882620
[TBL] [Abstract][Full Text] [Related]
4. [MR imaging of hepatocellular carcinoma using hepatocyte-specific contrast agent Gd-EOB-DTPA].
Tanaka O; Nishimura T; Yamagami T; Ichijo Y; Ouchi H; Ohno K; Mitsumoto Y; Mori T; Yoshikawa T
Nihon Shokakibyo Gakkai Zasshi; 2010 May; 107(5):703-11. PubMed ID: 20460843
[No Abstract] [Full Text] [Related]
5. [5. Inspection of Hepatocellular Carcinoma 3-Contrast for the Diagnosis of Hepatocellular Carcinoma: Techniques of Image Contrast and the Choice of MR Contrast Agent].
Kitoh Y
Nihon Hoshasen Gijutsu Gakkai Zasshi; 2016 May; 72(5):441-51. PubMed ID: 27211090
[No Abstract] [Full Text] [Related]
6. [The dynamic magnetic resonance study of focal liver lesions by FLASH sequences with bolus intravenous gadolinium-DTPA].
Olivetti L; Grazioli L; Maroldi R; Matricardi L; Milanesio L
Radiol Med; 1992 Apr; 83(4):353-60. PubMed ID: 1318558
[TBL] [Abstract][Full Text] [Related]
7. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
[TBL] [Abstract][Full Text] [Related]
8. Detection of hepatocellular carcinoma with dynamic MR imaging during intraarterial infusion of gadopentetate dimeglumine.
Fujita T; Ito K; Choji T; Honjo K; Matsumoto T; Arita T; Nakanishi T
AJR Am J Roentgenol; 1994 Oct; 163(4):865-6. PubMed ID: 8092025
[No Abstract] [Full Text] [Related]
9. Fibrolamellar hepatocellular carcinoma: MR appearance mimicking focal nodular hyperplasia.
Hamrick-Turner JE; Shipkey FH; Cranston PE
J Comput Assist Tomogr; 1994; 18(2):301-4. PubMed ID: 8126288
[TBL] [Abstract][Full Text] [Related]
10. Double contrast MR imaging of hepatocellular carcinoma evaluating lesion detection and conspicuity.
Akinci D; Oto A; Besim A; Akhan O; Abbasoglu O; Batman F; Eryilmaz M
Acad Radiol; 2002 Aug; 9 Suppl 2():S466-7. PubMed ID: 12188310
[No Abstract] [Full Text] [Related]
11. Receiver operating characteristic curve analysis, sensitivity comparison and individual difference.
Kawada T
Clin Radiol; 2012 Sep; 67(9):940. PubMed ID: 22608247
[No Abstract] [Full Text] [Related]
12. Comparison between areas with Gd-EOB-DTPA uptake and without in hepatocellular carcinomas on Gd-EOB-DTPA-enhanced hepatobiliary-phase MR imaging: pathological correlation.
Lee S; Kim SH; Park CK; Kim YS; Lee WJ; Lim HK
J Magn Reson Imaging; 2010 Sep; 32(3):719-25. PubMed ID: 20815073
[TBL] [Abstract][Full Text] [Related]
13. Gd-DTPA-DeA: a novel, liver-specific MRI contrast agent.
Kawamura Y
Acad Radiol; 2002 May; 9 Suppl 1():S102-3. PubMed ID: 12019839
[No Abstract] [Full Text] [Related]
14. Hepatocyte-specific magnetic resonance imaging contrast agents.
Fidler J; Hough D
Hepatology; 2011 Feb; 53(2):678-82. PubMed ID: 21274888
[No Abstract] [Full Text] [Related]
15. [Dynamic MRI].
Araki T; Ichikawa T; Nakajima H
Nihon Rinsho; 2001 Oct; 59 Suppl 6():292-5. PubMed ID: 11761959
[No Abstract] [Full Text] [Related]
16. Optimal scanning protocol of arterial dominant phase for hypervascular hepatocellular carcinoma with gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced MR.
Kagawa Y; Okada M; Kumano S; Katsube T; Imaoka I; Tanigawa N; Ishii K; Kudo M; Murakami T
J Magn Reson Imaging; 2011 Apr; 33(4):864-72. PubMed ID: 21448951
[TBL] [Abstract][Full Text] [Related]
17. Detection and characterization of focal liver lesions using superparamagnetic iron oxide-enhanced magnetic resonance imaging: comparison between ferumoxides-enhanced T1-weighted imaging and delayed-phase gadolinium-enhanced T1-weighted imaging.
Takahama K; Amano Y; Hayashi H; Ishihara M; Kumazaki T
Abdom Imaging; 2003; 28(4):525-30. PubMed ID: 14580096
[TBL] [Abstract][Full Text] [Related]
18. [Magnetic resonance tomography of focal hepatic lesions using the para-magnetic contrast medium, gadolinium DTPA. First clinical results].
Hamm B; Römer T; Felix R; Wolf KJ
Rofo; 1986 Dec; 145(6):684-91. PubMed ID: 3025957
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient.
Vogl TJ; Hammerstingl R; Schwarz W; Kümmel S; Müller PK; Balzer T; Lauten MJ; Balzer JO; Mack MG; Schimpfky C; Schrem H; Bechstein WO; Neuhaus P; Felix R
Invest Radiol; 1996 Nov; 31(11):696-708. PubMed ID: 8915751
[TBL] [Abstract][Full Text] [Related]
20. Dynamic sequential MR imaging of focal liver lesions: initial experience in 22 patients at 1.5 T.
Schmiedl U; Kölbel G; Hess CF; Klose U; Kurtz B
J Comput Assist Tomogr; 1990; 14(4):600-7. PubMed ID: 2164538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
